Clinical Trial Update: A Phase II/III Study of Efficacy and Safety of SHR7280 Tablets in Subjects With Menorrhagia With Uterine Fibroids [Phase 2, Phase 3]

View source ↗

Summary

Phase II/III clinical trial evaluating SHR7280 tablets for efficacy and safety in menorrhagia due to uterine fibroids; recruiting patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menorrhagia
• Uterine Fibroids

Drugs mentioned

• SHR7280

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Uterine Fibroids With Menorrhagia | Phase 2, Phase 3 | Status: RECRUITING